Chapter 26. Controls on NHS Medicines Prescribing and Expenditure in the UK (A Historical Perspective) with some International Comparisons

  1. John P Griffin BSc, PhD, MBBS, FRCP, FRCPath, FFPM1,
  2. John O'Grady MD, FRCP, FFPM, FBIRA, MRCPath2
  1. John P Griffin,
  2. Jane R Griffin

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987391.ch26

The Textbook of Pharmaceutical Medicine, Fifth Edition

The Textbook of Pharmaceutical Medicine, Fifth Edition

How to Cite

Griffin, J. P. and Griffin, J. R. (2007) Controls on NHS Medicines Prescribing and Expenditure in the UK (A Historical Perspective) with some International Comparisons, in The Textbook of Pharmaceutical Medicine, Fifth Edition (eds J. P. Griffin and J. O'Grady), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987391.ch26

Editor Information

  1. 1

    Director, Asklepieion Consultancy Ltd., Visiting Professor, University of Surrey Postgraduate Medical School, Former Director, Association of the British Pharmaceutical Industry, London, Formerly Professional Head of the Medicines Division, DHSS, London

  2. 2

    Visiting Professor of Clinical Pharmacology, University of London

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 15 DEC 2005

ISBN Information

Print ISBN: 9780727918406

Online ISBN: 9780470987391

SEARCH

Keywords:

  • marketing authorisation;
  • product licence;
  • good manufacturing practice;
  • national health service;
  • United Kingdom

Summary

This chapter contains sections titled:

  • Introduction

  • The NHS and Community Care Act 1990

  • The Problem of the Rising NHS Medicines Bill

  • Prescription Charges for NHS Medicines

  • The Pharmaceutical Price Regulation Scheme

  • The Drug Tariff and Reference Pricing

  • Contract Purchase of Medicines from Cheap Sources

  • The MacGregor Committee

  • Generic Substitution

  • Enforced Price Reductions

  • Limited or Selected Lists

  • The Indicative Prescribing Scheme and GP Fundholding

  • The Development of Primary Care Groups (PCGs)

  • Changing the Legal Status of Medicines from Prescription only to Over-the-Counter Availability

  • Encouragement to Prescribe Generically

  • The National Institute for Clinical Excellence

  • The European Transparency Directive

  • Supply of Controlled Drugs

  • The British National Formulary

  • International Comparisons